Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors Meeting Abstract
| Authors: | Desai, A. V.; Gajjar, A.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Sabnis, A. J.; Foster, J.; Shusterman, S.; Yoon, J.; Weiss, B.; Abdelbaki, M. S.; Farid-Kapadia, M.; Meneses-Lorente, G.; Cardenas, A.; Hutchinson, K. E.; Bergthold, G.; Maneval, E. C.; Fox, E.; Robinson, G. W. |
| Abstract Title: | Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors |
| Meeting Title: | 51st Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 66 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 23-26 |
| Meeting Location: | Lyon, France |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2019-12-01 |
| Start Page: | S69 |
| End Page: | S70 |
| Language: | English |
| ACCESSION: | WOS:000488458000129 |
| PROVIDER: | wos |
| PUBMED: | 31568621 |
| DOI: | 10.1002/pbc.27989 |
| Notes: | Meeting Abstract: FP122 SIOP19-1372 -- Source: Wos |
